Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat

被引:33
作者
Borovec, S [1 ]
Broumis, C [1 ]
Adcock, W [1 ]
Fang, R [1 ]
Uren, E [1 ]
机构
[1] CSL Ltd, Bioplasma Div, Virol Grp, Broadmeadows 3047, Australia
关键词
D O I
10.1006/biol.1998.0146
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
To determine the efficacy of a clean-in-place system for the inactivation of viruses present in human plasma, the effect of 0.1 M sodium hydroxide at 60 degrees C on viral infectivity was investigated. Inactivation of the following model and relevant viruses were followed as a function of time: human hepatitis A virus (HAV), canine parvovirus (CPV; a model for human parvovirus B-19) pseudorabies virus (PRV, a model for hepatitis B virus), and bovine viral diarrhoea virus (BVDV, a model for hepatitis C virus and human immunodeficiency virus). Infectivity of CPV was determined by a novel in situ EIA method which will prove useful for studies to validate parvovirus inactivation or removal, infectivity of BVDV, PRV and CPV were shown to be reproducibly inactivated below the limit of detection by 0.1 M NaOH at 60 degrees C within 30 s. HAV was inactivated to below the limit of detection within 2 min. Treatment with heat alone also resulted in some log reduction for all Viruses tested except for CPV which remained unaffected after heating at 60 degrees C for 16 min. Treatment of HAV with hydroxide alone (up to 1.0 M) at 15 degrees C did not lead to rapid inactivation. Collectively, these data suggest that 0.1 M NaOH at 60 degrees C for two min should be sufficient to inactivate Viruses present in process residues. (C) 1998 The International Association of Biological Standardization.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 16 条
[1]  
Biesert L, 1996, CLIN EXP RHEUMATOL, V14, pS47
[2]   RAPID AND EFFICIENT PURIFICATION OF HEPATITIS-A VIRUS FROM CELL-CULTURE [J].
BISHOP, NE ;
HUGO, DL ;
BOROVEC, SV ;
ANDERSON, DA .
JOURNAL OF VIROLOGICAL METHODS, 1994, 47 (1-2) :203-216
[3]   Single-antibody in situ enzyme immunoassay for infectivity titration of Hepatitis A virus [J].
Borovec, S ;
Uren, E .
JOURNAL OF VIROLOGICAL METHODS, 1997, 68 (01) :81-87
[4]  
BURNOUF T, 1993, DEV BIOL STAND, V81, P199
[5]   STRUCTURE, SEQUENCE, AND FUNCTION CORRELATIONS AMONG PARVOVIRUSES [J].
CHAPMAN, MS ;
ROSSMANN, MG .
VIROLOGY, 1993, 194 (02) :491-508
[6]   VALIDATION OF VIRUS INACTIVATION AND REMOVAL FOR THE MANUFACTURING PROCEDURE OF 2 IMMUNOGLOBULINS AND A 5-PERCENT SERUM-PROTEIN SOLUTION TREATED WITH BETA-PROPIOLACTONE [J].
DICHTELMULLER, H ;
RUDNICK, D ;
BREUER, B ;
GANSHIRT, KH .
BIOLOGICALS, 1993, 21 (03) :259-268
[7]   IODINE-MEDIATED INACTIVATION OF LIPID-ENVELOPED AND NONLIPID-ENVELOPED VIRUSES IN HUMAN ANTITHROMBIN-III CONCENTRATE [J].
HIGHSMITH, F ;
XUE, H ;
CHEN, X ;
BENADE, L ;
OWENS, J ;
SHANBROM, E ;
DROHAN, W .
BLOOD, 1995, 86 (02) :791-796
[8]   EARLY STAGES OF ENTEROVIRUS INFECTION [J].
HOLLAND, JJ ;
HOYER, BH .
COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY, 1962, 27 :101-&
[9]   SIZE AND ANTIGENIC COMPARISONS AMONG THE STRUCTURAL PROTEINS OF SELECTED AUTONOMOUS PARVOVIRUSES [J].
MENGELING, WL ;
RIDPATH, JF ;
VORWALD, AC .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :825-837
[10]   Virus inactivation by pepsin treatment at pH 4 of IgG solutions: Factors affecting the rate of virus inactivation [J].
Omar, A ;
Kempf, C ;
Immelmann, A ;
Rentsch, M ;
Morgenthaler, JJ .
TRANSFUSION, 1996, 36 (10) :866-872